Title: Mats Peter Clarsund: Innovator in Microbial Infection Treatments
Introduction
Mats Peter Clarsund is an inventor based in Lund, Sweden. He is associated with Enzymatica AB, where he focuses on developing innovative treatments for microbial infections. Despite having no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Mats Peter Clarsund has filed several patent applications that showcase his innovative ideas. One of his latest applications is titled "Novel Treatments." This invention provides polypeptides with protease activity for treating or preventing microbial infections in subjects with or susceptible to immunodeficiency. The polypeptides can be administered in various forms, such as mouth sprays, nasal sprays, lozenges, pastilles, chewing gum, or liquids. They are particularly useful in treating or preventing rhinorrhea and fungal infections of the oral cavity and gum sores. One embodiment of this invention includes a trypsin enzyme derived from Atlantic cod.
Another significant application is "Novel Methods, Polypeptides and Uses Thereof." This invention outlines methods for producing recombinant polypeptides with serine protease activity. It also describes polypeptides obtainable through these methods and their applications in medicine, cosmetics, and industry. The invention highlights recombinantly expressed mutants of trypsin I from Atlantic cod, which exhibit improved stability and catalytic properties compared to the wildtype trypsin.
Conclusion
Mats Peter Clarsund is a dedicated inventor whose work focuses on innovative solutions for microbial infections. His latest patent applications reflect his commitment to advancing medical treatments. His contributions to the field are significant, and his ongoing research may lead to impactful developments in healthcare.